Handlevogn 1 Varer $305.99
Generic Glyxambi (Linagliptin/empagliflozin)
Glyxambi
Glyxambi is a prescription medication used to control blood sugar in adults with type 2 diabetes. It combines empagliflozin and linagliptin to help regulate glucose levels and support overall glycemic management.
Velg Doser: 25/5mg
25/5mg
90piller
Glyxambi $621.59
$517.99
$5.76 per pille
+ Gratis standard luftpost tjeneste
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
LEGG TIL I HANDLEKURVEN
spare: $21.60
25/5mg
60piller
Glyxambi $424.79
$353.99
$5.90 per pille
+ Gratis standard luftpost tjeneste
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
LEGG TIL I HANDLEKURVEN
spare: $6.00
25/5mg
30piller
Glyxambi $215.99
$179.99
$6.00 per pille
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
LEGG TIL I HANDLEKURVEN
spare: $0.00
Din bestilling vil bli pakket trygt og sikkert, og normalt innen 24 timer. Dette er nøyaktig hvordan pakken vil se ut (bilder av en ekte leveranse). Den har en størrelse og en utseende som et vanlig privat brev (9.4x4.3x0.3 tommer eller 24x11x0.7cm) og det avslører ikke innholdet
Land Leveringsmåte Leveringstid Pris  
Levering 14-21 dager 0$ Sporing # tilgjengelig i 4 dager
Levering 9-14 dager 30$ Sporing # tilgjengelig i 2 dager
Frakt over hele verden Konfidensialitet og anonymitet garanti
Trygt og sikkert Diskrete pakker
Afsendelse af ordrer indenfor 24 timer 100% levering success
Attester Produktbeskrivelse
Det er ingen tilbakemeldinger for dette produktet for øyeblikket, men du kan være den første til å legge til en ellers kan du lese mer på tilbakemeldingssiden om relaterte produkter .
Legg Til Anmeldelse

Common Use
Glyxambi is prescribed for adults with type 2 diabetes whose blood sugar is not adequately controlled by diet and exercise alone. It helps lower blood glucose by promoting glucose excretion through urine and enhancing the body’s natural insulin response. Maintaining proper blood sugar levels reduces the risk of diabetes-related complications.

Dosage and Direction
The recommended dose is one tablet taken orally once daily, with or without food, or as directed by a healthcare provider. Swallow the tablet whole with water and take it at the same time each day. Do not change the dose without consulting your doctor.

Precautions
Before using Glyxambi, inform your doctor if you have kidney or liver disease, low blood pressure, or a history of urinary tract infections. Monitor blood sugar regularly and stay hydrated to avoid dehydration. Avoid driving or operating machinery if you experience dizziness or low blood sugar.

Contraindications
Glyxambi should not be used in patients with type 1 diabetes, diabetic ketoacidosis, severe kidney impairment, or known hypersensitivity to empagliflozin, linagliptin, or any component of the tablet.

Possible Side Effects
Common side effects include urinary tract infections, hypoglycemia (especially when combined with insulin), headache, and nasopharyngitis. Rare but serious effects may include dehydration, kidney problems, or ketoacidosis. Seek medical attention if severe symptoms occur.

Drug Interaction
Glyxambi may interact with insulin, sulfonylureas, diuretics, or other medications affecting kidney function or blood sugar. These interactions can increase the risk of hypoglycemia or dehydration. Inform your healthcare provider about all medications and supplements you are taking.

Missed Dose
If a dose is missed, take it as soon as you remember. If it is close to the time of the next dose, skip the missed dose. Do not take a double dose to make up for a missed one.

Overdose
Overdose may cause severe hypoglycemia, dehydration, or kidney problems. Seek immediate medical attention if an overdose is suspected.

Storage
Store Glyxambi tablets at room temperature, away from heat, moisture, and direct sunlight. Keep out of reach of children. Do not use after the expiration date.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Attester
Elliot, 53, Tennessee
"Jeg har akkurat blitt 53år, ikke så gammel, og har vært plaget av erektil dysfunksjon i mer enn åtte år. Ulike teknikker og medisiner hjalp ikke meg eller var nyttig bare for en stund og deretter problemet tilbake. Bare med Cialis kan jeg få perfekt ...
les mer»
Michael Tucker, Stanford
Din gruppen er den mest profesjonelle av alle nettapotek jeg noensinne har gjort forretninger med. Ser frem til å handle med dere i fremtiden, og jeg vil fortelle familie og venner til å gjøre det samme.
les mer»
Nyheter
Prostate cancer screening only for "a few thousand" high risk men
Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
'It's not a nice world to bring children into': Births fall to the lowest level in 50 years
Live births in England and Wales are at their lowest since 1977, while the age of first-time mothers has also risen.
Resident doctors in England to strike for 16th time over pay
British Medical Association resident doctor members in England announce new strike for four days from 15 June.
'We knew somebody would die': Teenage patients 'ignored' before fatal NHS trust failures
Mental health patients say nobody listened to their concerns about a north-east England trust.
Forsendelsesmåte